Vland Biotech (603739.SH) released its performance for the first three quarters, with net profit attributable to the parent company of 62.9 million yuan, a year-on-year increase of 1.82%.

Zhitong Finance APP News, Vland Biotech (603739.SH) disclosed its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 1.097 billion yuan, up 7.97% year on year; net profit attributable to the parent company was 62.90 million yuan, up 1.82% year on year; net profit after deducting non-recurring gains and losses was 41.11 million yuan, up 79.25% year on year; basic earnings per share were 0.25 yuan.